Clinical Trial Update: Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease ) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating novel first-line therapies for Grade II acute graft-versus-host disease in stem cell transplant patients, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Daihong Liu | Conditions: GVHD,Acute, Stem Cell Transplant Complications | Phase 2 | Status: RECRUITING